Pulmonary involvement in mixed connective tissue disease: Comparison with other collagen vascular diseases using high resolution CT

Journal of Computer Assisted Tomography

Volumn 26, Issue 3, 2002, Pages 349-357

  Saito, Yasuharu ^a   Terada, Masaki ^a   Takada, Toshinori ^a   Ishida, Takashi ^a   Moriyama, Hiroshi ^a   Ooi, Hidemi ^a   Hasegawa, Takashi ^a   Tsukada, Hiroki ^a   Suzuki, Eiichi ^a   Gejyo, Fumitake ^a   Kihara, Yoshinori ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Computed tomography, high resolution; Connective tissue, diseases; Lung; Lung, interstitial disease

Indexed keywords

BIOLOGICAL ORGANS; COLLAGEN; MUSCULOSKELETAL SYSTEM; PULMONARY DISEASES; TISSUE;

COMPUTED TOMOGRAPHY, HIGH RESOLUTION; CONNECTIVE TISSUE DISEASE; CT-SCAN; HIGH RESOLUTION; HIGH RESOLUTION CT; INTERSTITIALS; LUNG; LUNG, INTERSTITIAL DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR DISEASE;

COMPUTERIZED TOMOGRAPHY;

ADULT; AGED; ARTICLE; COLLAGEN DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; POLYMYOSITIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

EID: 0036263486     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-200205000-00006     Document Type: Article

References (38)

1. Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)
2. Clinical and serologic characteristics of patients with overlap syndrome: Is mixed connective tissue disease a distinct clinical entity?
3. Naming names! Comment on the article by Smolen and Steiner
4. Clinical, immunologic, and immunogenetic evidence that mixed connective tissue disease is a distinct entity: Comment on the article by Smolen and Steiner
5. Mixed connective tissue disease dispute
6. Mixed connective tissue disease-goodbye to all that
7. Undifferentiated connective tissue diseases: Mixed or muddled?
8. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease
9. Lungs in mixed connective tissue disease
10. Assessment of diffuse infiltrative lung disease: Comparison of conventional CT and high-resolution CT
11. Interstitial lung disease in progressive systemic sclerosis: High-resolution CT versus radiography
12. Pulmonary involvement in progressive systemic sclerosis: Sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage
13. Lung changes in rheumatoid arthritis: CT findings
14. Discrete lung involvement in systemic lupus erythematosus: CT assessment
15. High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis
16. Pulmonary involvement in polymyositis and dermatomyositis: Sequential evaluation with CT
17. Interstitial lung disease in association with polymyositis-dermatomyositis: Long-term follow-up CT evaluation in seven patients
18. Pulmonary involvement in mixed connective tissue disease: High-resolution CT findings in 41 patients
19. Preliminary diagnostic criteria for classification of mixed connective tissue disease
20. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
21. The 1982 revised criteria for the classification of systemic lupus erythematosus
22. Polymyositis and dermatomyositis (first of two parts)
23. Spirometric standards for healthy nonsmoking adults
24. Standardized single breath normal values for carbon monoxide diffusing capacity
25. Diagnostic criteria for classification of MCTD
26. Syndrom de Sharp
27. Classification and diagnostic criteria for mixed connective tissue disease
28. Severe pulmonary involvement in mixed connective tissue disease
29. Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance
30. Clinical and subclinical alveolitis in collagen vascular diseases: Contribution of alpha 2-macroglobulin levels in BAL fluid
31. Expansion of selected V delta 1+ gamma delta T cells in systemic sclerosis patients
32. Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjogren's syndrome
33. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage
34. Pulmonary involvement in the collagen vascular diseases
35. Pulmonary and cardiac manifestations of polymyositis-dermatomyositis
36. Clinical significance of antibodies to a 68 kDa U1RNP polypeptide in connective tissue disease
37. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth
38. The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients